Alembic Pharmaceuticals Secures USFDA Approval for Generic Paroxetine Extended-Release Tablets
Approval Strengthens Alembic’s US Generics Portfolio
New Delhi, March 30: Alembic Pharmaceuticals Ltd on Monday announced that it has received final approval from the United States Food and Drug...
New Delhi, February 24: Alembic Pharmaceuticals on Tuesday announced that it has received final approval from the US Food and Drug Administration to market its generic version of Efinaconazole Topical Solution 10 percent in the United States.The approval marks a significant regulatory...